Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA2 | Q15349 | 10/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | MAP4K1 | Q92918 | 3/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.37 |
| ▸ | WEE1 | P30291 | 1/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18135441 | 0.82 | LRRK2 (0.43) | RPS6KA2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL18128526 | 0.80 | NQO2 (0.36) | RPS6KA2MAP4K1ERN1 | |
| SCHEMBL30615194 | 0.78 | NQO2 (0.38) | ERN1 | |
| SCHEMBL29091666 | 0.78 | NQO2 (0.38) | ERN1 | |
| SCHEMBL15857826 | 0.75 | KDM4E (0.45) | — | |
| SCHEMBL27241457 | 0.72 | HTR5A (0.39) | RPS6KA2MAP4K1CHEK1WEE1LRRK2 | |
| SCHEMBL31010652 | 0.72 | HTR5A (0.39) | RPS6KA2MAP4K1CHEK1WEE1LRRK2 | |
| SCHEMBL17836851 | 0.71 | RPS6KA2 (0.52) | RPS6KA2MAP4K1LRRK2 | |
| SCHEMBL18135227 | 0.69 | SMN1; SMN2 (0.48) | MAP4K1LRRK2 | |
| SCHEMBL29091679 | 0.69 | SLC6A3 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016164675-A1 | SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | ARAXES PHARMA LLC (US) | 2016-10-13 | — | — | WO | disclosed |